NASDAQ:BZ

KANZHUN LIMITED (NASDAQ: BZ) Demonstrates Robust Financial Health and User Expansion

Font: Financial Modeling Prep  • May 20, 2026

Market Chart
  • KANZHUN LIMITED surpassed analyst earnings per share estimates, reporting $0.27 per share.
  • Despite a slight revenue miss, the company achieved significant year-over-year top-line growth, with quarterly revenue reaching $300.38 million.
  • The BOSS Zhipin platform showcased strong user engagement and a solid financial position, marked by a P/E ratio of 16.30 and a current ratio of 4.66.

KANZHUN LIMITED (NASDAQ: BZ) operates the BOSS Zhipin online recruitment platform in China. The company connects job seekers with employers, focusing on a mobile-first approach. It has become a prominent player in the country's competitive digital hiring market, leveraging technology to match candidates with suitable enterprise clients.

KANZHUN LIMITED reported quarterly earnings of $0.27 per share, which beat the analyst consensus estimate of $0.25. As highlighted by Zacks, this performance also shows an improvement from the $0.24 per share earned in the same quarter one year ago, indicating positive earnings growth for the company.

The company also announced quarterly revenue of $300.38 million. This figure narrowly missed the analyst consensus estimate of $301.91 million by 0.81%. Despite the miss, the revenue marks a significant increase from the $265.03 million reported in the year-ago quarter, showing continued top-line expansion.

This revenue growth is supported by strong user engagement. As reported by GlobeNewswire, KANZHUN LIMITED's total paid enterprise customers grew by 10.9% to 7.1 million over the last twelve months. Average monthly active users also increased to 60.9 million, demonstrating the platform's expanding reach and user base.

KANZHUN LIMITED maintains a solid financial position. The company has a price-to-earnings (P/E) ratio of 16.30, which measures its current share price relative to its per-share earnings. Furthermore, its current ratio is a strong 4.66, suggesting it has more than enough assets to cover its short-term liabilities.

Market Overview
LIMN
Liminatus Pharma, Inc. Class A Common Stock
$0.27
43.24%
SBFM
Sunshine Biopharma, Inc.
$0.48
30.14%
SOXS
Direxion Daily Semiconductor Bear 3X ETF
$8.57
0.35%
TZA
Direxion Daily Small Cap Bear 3X ETF
$4.80
-0.62%
NVDA
NVIDIA Corporation
$219.42
-1.81%
WOK
WORK Medical Technology Group Ltd.
$0.16
-17.67%
CXAI
CXApp Inc.
$0.21
18.65%
RGTI
Rigetti Computing, Inc.
$21.16
25.36%
NIVF
NewGenIvf Group Limited
$1.08
46.12%
CODX
Co-Diagnostics, Inc.
$3.76
57.32%